chemotherapy in the postoperative period
To 58 patients the chemotherapy was spent adjuvantnaja. The scheme and quantity of courses of chemotherapy have been defined by references of the oncologist - himioterapevta. Treatment spent with including 5 - ftoruratsila under following schemes: 32 patients received only kselodu (kapetsitabin) 1250 mg/m 2 times a day with 1 for 14 day, each 3 weeks; to 14 patients - boljusno intraperitonialno for 10 days after operation it was entered karboplatin 150 mg through established in advance intraoperatsionno a catheter into an abdominal cavity + kseloda (kapetsitabin) 1250 mg/m 2 times a day with 1 for 14 days everyone of 3 weeks; to 7 patients - under scheme CapOX (XELOX) oksaliplatin 130 mg/m in 1 day, kseloda (kapetsitabin) on 1000 mg/m 2 times a day with 1 for 14 days everyone of 3 weeks; to 5 patients - 5-ftoruratsil 450 mg/m a day i.v. 30минутная infusion with 1 for 5 days + lejkovorin 50 mg/m a day i.v. with 1 for 5 day, each 4 weeks.
Intraabdominal himioinfuziju spent the patient with established on dooperatsionnom a stage the diagnosis crico a-cellular carcinoma of the stomach. During operation left a catheter in an abdominal cavity and entered a platinum preparation for 10 days after operation then a catheter deleted.
2.5.
More on topic chemotherapy in the postoperative period:
- an estimation of complications in the postoperative period
- complications in the postoperative period
- 3.7 Postoperative period.
- Clinico-Immunologichesky characteristics of a current of the postoperative period at the patients receiving immunomodulirujushchuju therapy
- CHAPTER 4. INFLUENCE of the OBEMAHIRURGICHESKY INTERVENTION With APPLICATION INTRAOPERATSIONNOJ of FLUORESCENT DIAGNOSTICS ON the CURRENT of the POSTOPERATIVE PERIOD At PATIENTS WITH MALIGNANT GLIOMAMI the BRAIN.
- 1.2. Influence of design [1] endoprosthesises and osteal cements for the term of its "service" in the postoperative period.
- 6.3 Early chemotherapy
- the genetic factors defining efficiency of chemotherapy
- § 3. The period of 1964 – the modern period
- 3.5.3. Quality of a life sick of muscularly-invazivnym cancer of a bladder in stage T2bN0M0G1-G3-T3aN0M0G1-G3 after organosohranjajushchego the operative treatment, receiving system chemotherapy and (or) radial therapy
- comparison of indicators of survival rate of patients I, II groups receiving system chemotherapy and (or) radial therapy, with patients of groups of observation IA and IIA
- postoperative complications.
- postoperative chemotherapeutic treatment.
- the Characteristic of postoperative complications.
- Diagnostics of postoperative complications.
- the Estimation of gravity of a condition of patients at advance of a postoperative peritonitis
- postoperative monitoring of patients
- the analysis of frequency of development of postoperative complications depending on operative measure volume
- postoperative monitoring of patients.